Postprandial hyperlipidemia in Zucker diabetic fatty fa/fa rats, an animal model of type II diabetes, and its amelioration by acyl-CoA:cholesterol acyltransferase inhibition

Jpn J Pharmacol. 2001 May;86(1):127-9. doi: 10.1254/jjp.86.127.

Abstract

Postprandial hyperlipidemia (PH) is frequently observed in diabetic patients. We performed an oral fat-loading test in Zucker diabetic fatty (ZDF) fa/fa rats, a model for type II diabetes, to determine whether PH was induced in the rats. Post fat-loading changes in serum cholesterol and triglyceride levels were significantly greater in the fa/fa rats than those seen in their lean littermates and an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor significantly reduced these levels by 24% and 31%, respectively. Therefore, we confirmed that PH appeared in ZDF fa/fa rats by fat loading and ACAT inhibition may be a potential treatment for PH.

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Blood Glucose / metabolism
  • Body Weight / drug effects
  • Cholesterol / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism*
  • Dietary Fats / pharmacokinetics
  • Hyperlipidemias / blood*
  • Postprandial Period / physiology*
  • Rats
  • Rats, Zucker
  • Sterol O-Acyltransferase / antagonists & inhibitors*
  • Triglycerides / blood

Substances

  • Anticholesteremic Agents
  • Blood Glucose
  • Dietary Fats
  • Triglycerides
  • Cholesterol
  • Sterol O-Acyltransferase